328 related articles for article (PubMed ID: 29669758)
21. Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma.
Mataki H; Seki N; Chiyomaru T; Enokida H; Goto Y; Kumamoto T; Machida K; Mizuno K; Nakagawa M; Inoue H
Int J Oncol; 2015 Mar; 46(3):1039-50. PubMed ID: 25522678
[TBL] [Abstract][Full Text] [Related]
22. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
23. Tumor-Promoting Activity of Long Noncoding RNA LINC00466 in Lung Adenocarcinoma via miR-144-Regulated HOXA10 Axis.
Ma T; Hu Y; Guo Y; Yan B
Am J Pathol; 2019 Nov; 189(11):2154-2170. PubMed ID: 31381886
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Teashirt Homolog 2 suppresses cell proliferation and predicts the favorable survival of Lung Adenocarcinoma.
Zhao S; Guo X; Mizutani KI; Yamaguchi R; Yamada S; Gu C; Uramoto H
Int J Med Sci; 2021; 18(9):1980-1989. PubMed ID: 33850468
[No Abstract] [Full Text] [Related]
25. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
Deng X; Ye D; Hua K; Song H; Luo Q; Munankarmy A; Liu D; Zhou B; Zheng W; Zhou X; Ji C; Wang X; Yu Y; Fang L
Cell Death Dis; 2021 Aug; 12(9):810. PubMed ID: 34446703
[TBL] [Abstract][Full Text] [Related]
26. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
27. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.
Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G
J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
29.
Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M
Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
[TBL] [Abstract][Full Text] [Related]
31. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA MIR22HG is down-regulated in prostate cancer.
Shen H; Weng XD; Yang D; Wang L; Liu XH
Math Biosci Eng; 2019 Dec; 17(2):1776-1786. PubMed ID: 32233607
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
Liu L; Ni J; He X
Dis Markers; 2018; 2018():5736716. PubMed ID: 30154938
[TBL] [Abstract][Full Text] [Related]
34. DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.
Luo J; Liu K; Yao Y; Sun Q; Zheng X; Zhu B; Zhang Q; Xu L; Shen Y; Ren B
Cancer Lett; 2019 Jul; 453():45-56. PubMed ID: 30928384
[TBL] [Abstract][Full Text] [Related]
35. TNF‑α inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF‑1α/VASP signaling pathway.
Liu W; Chen X; He Y; Tian Y; Xu L; Ma Y; Hu P; Su K; Luo Z; Wei L; Zhang J
Oncol Rep; 2019 Apr; 41(4):2418-2430. PubMed ID: 30816548
[TBL] [Abstract][Full Text] [Related]
36. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
[TBL] [Abstract][Full Text] [Related]
37. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
38. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
[TBL] [Abstract][Full Text] [Related]
39. Identification of Long Noncoding RNA MIR22HG as a Novel Biomarker in Thyroid Cancer.
Qin L; Luo JZ; Tang XL; Han CG
Pathol Oncol Res; 2019 Apr; 25(2):703-710. PubMed ID: 30539522
[TBL] [Abstract][Full Text] [Related]
40. DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
Hamada K; Tian Y; Fujimoto M; Takahashi Y; Kohno T; Tsuta K; Watanabe SI; Yoshida T; Asamura H; Kanai Y; Arai E
Carcinogenesis; 2021 Feb; 42(2):169-179. PubMed ID: 33152763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
